ANDA 40558, held by Able. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 40558 (Promethazine Hydrochloride), held by Able, was first approved by FDA on Jul 1, 2004, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 1, 2004 | Original application | Approved | None posted |
| Promethazine Hydrochloride12.5MG · tablet;oral | Promethazine Hydrochloride | Discontinued |
| Promethazine Hydrochloride25MG · tablet;oral | Promethazine Hydrochloride | Discontinued |
| Promethazine Hydrochloride50MG · tablet;oral | Promethazine Hydrochloride | Discontinued |
| Jun 9, 2005 | Supplement 2Labeling | Approved | None posted |
| Jul 1, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters